Alliant Sale to Choice Health at Home

Helix Health Capital Advisors served as the exclusive financial advisor to Alliant Home Health, Palliative, and Hospice Care (“Alliant”) in connection with its sale to Choice Health at Home (“Choice”), a home-based care platform backed by Trive Capital and Coltala Holdings. The transaction closed on November 12, 2025. Additional information on the transaction is available in the press release here.

About Alliant

Alliant is a Colorado provider that has served its communities for more than a decade. The company is a Medicare-certified skilled home health provider with integrated hospice operations, supporting patients and families across a range of care needs in the home setting.

Click to learn more about Alliant.

Alliant’s home health service line includes skilled nursing, physical therapy, and occupational therapy, delivered by experienced clinical teams focused on improving outcomes and supporting independence following acute events and across chronic conditions. The integrated hospice offering further extends continuity of care as patient needs evolve.

Choice Health at Home, headquartered in Tyler, Texas, is a multi-state provider of home health, hospice, personal care, and rehabilitation services. The combination reflects continued investment in scaled home-based care platforms as payers and referral sources increasingly emphasize quality performance, responsiveness, and coordinated care delivery—while operators navigate labor constraints, documentation requirements, and the operational complexity that comes with serving higher-acuity patients in the home. In this environment, platforms continue to prioritize partnerships with regional providers that bring strong local execution and a broader in-home continuum.

 

Helix advised Alliant’s leadership team throughout the transaction, including positioning and preparation, coordinating a focused buyer outreach process, managing diligence, and supporting negotiations and execution through closing. The transaction further reinforces Helix’s work across healthcare services, advising owners, management teams, and investors on M&A and capital solutions in the lower middle market.

 
Previous
Previous

Psychology Practice Sale to a Family Office

Next
Next

EBITDA vs. EBPC: Demystifying Valuation in Physician Practice Acquisitions